Relationships between sunitinib plasma concentration and clinical outcomes in Japanese patients with metastatic renal cell carcinoma

被引：0
|
作者：
Shinya Takasaki
Yoshihide Kawasaki
Masafumi Kikuchi
Masaki Tanaka
Masato Suzuka
Aoi Noda
Yuji Sato
Shinichi Yamashita
Koji Mitsuzuka
Hideo Saito
Akihiro Ito
Hiroaki Yamaguchi
Yoichi Arai
Nariyasu Mano
机构：
[1] Tohoku University Hospital,Department of Pharmaceutical Sciences
[2] Tohoku University Graduate School of Medicine,Department of Urology
[3] Sendai Medical Center,Department of Urology
来源：
International Journal of Clinical Oncology | 2018年 / 23卷
关键词：
Renal cell carcinoma; Tyrosine kinase inhibitor; Sunitinib; Pharmacokinetics; Therapeutic drug monitoring;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：936 / 943
页数：7
相关论文
共 50 条
  • [1] Relationships between sunitinib plasma concentration and clinical outcomes in Japanese patients with metastatic renal cell carcinoma
    Takasaki, Shinya
    Kawasaki, Yoshihide
    Kikuchi, Masafumi
    Tanaka, Masaki
    Suzuka, Masato
    Noda, Aoi
    Sato, Yuji
    Yamashita, Shinichi
    Mitsuzuka, Koji
    Saito, Hideo
    Ito, Akihiro
    Yamaguchi, Hiroaki
    Arai, Yoichi
    Mano, Nariyasu
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2018, 23 (05) : 936 - 943
  • [2] Sunitinib treatment for patients with clear-cell metastatic renal cell carcinoma: clinical outcomes and plasma angiogenesis markers
    Loukas F Kontovinis
    Konstantinos T Papazisis
    Panagiota Touplikioti
    Charalambos Andreadis
    Despoina Mouratidou
    Alexandros H Kortsaris
    BMC Cancer, 9
  • [3] Sunitinib treatment for patients with clear-cell metastatic renal cell carcinoma: clinical outcomes and plasma angiogenesis markers
    Kontovinis, Loukas F.
    Papazisis, Konstantinos T.
    Touplikioti, Panagiota
    Andreadis, Charalambos
    Mouratidou, Despoina
    Kortsaris, Alexandros H.
    BMC CANCER, 2009, 9
  • [4] CLINICAL OUTCOMES OF AXITINIB VERSUS SUNITINIB AS A FIRST-LINE THERAPY FOR METASTATIC RENAL CELL CARCINOMA IN JAPANESE PATIENTS
    Kiso, Yusuke
    Inoue, Takamitsu
    Nara, Taketoshi
    Kanda, Sohei
    Numakura, Kazuyuki
    Tsuruta, Hiroshi
    Saito, Mitsuru
    Narita, Shintaro
    Satoh, Shigeru
    Habuchi, Tomonori
    JOURNAL OF UROLOGY, 2018, 199 (04): : E874 - E874
  • [5] Clinical Outcomes for Patients with Metastatic Renal Cell Carcinoma Treated with Alternative Sunitinib Schedules
    Atkinson, Bradley J.
    Kalra, Sarathi
    Wang, Xuemei
    Bathala, Tharakeswara
    Corn, Paul
    Tannir, Nizar M.
    Jonasch, Eric
    JOURNAL OF UROLOGY, 2014, 191 (03): : 611 - 618
  • [6] Management of Adverse Events in Patients with Metastatic Renal Cell Carcinoma Treated with Sunitinib and Clinical Outcomes
    Arakawa-Todo, Maki
    Yoshizawa, Takahiko
    Zennami, Kenji
    Nishikawa, Genya
    Kato, Yoshiharu
    Kobayashi, Ikuo
    Kajikawa, Keishi
    Yamada, Yoshiaki
    Matsuura, Katsuhiko
    Tsukiyama, Ikuto
    Saito, Hiroko
    Hasegawa, Takaaki
    Nakamura, Kogenta
    Sumitomo, Makoto
    ANTICANCER RESEARCH, 2013, 33 (11) : 5043 - 5050
  • [7] Clinical outcomes in patients with metastatic renal cell carcinoma receiving everolimus or temsirolimus after sunitinib
    Iacovelli, Roberto
    Carteni, Giacomo
    Milella, Michele
    Berardi, Rossana
    Di Lorenzo, Giuseppe
    Verzoni, Elena
    Rizzo, Mimma
    Santoni, Matteo
    Procopio, Giuseppe
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2014, 8 (3-4): : E121 - E125
  • [8] Re: Clinical Outcomes for Patients with Metastatic Renal Cell Carcinoma Treated with Alternative Sunitinib Schedules
    Zigeuner, Richard
    EUROPEAN UROLOGY, 2014, 66 (04) : 785 - 785
  • [9] Sunitinib in patients with metastatic renal cell carcinoma
    Motzer, Robert J.
    Rini, Brian I.
    Bukowski, Ronald M.
    Curti, Brendan D.
    George, Daniel J.
    Hudes, Gary R.
    Redman, Bruce G.
    Margolin, Kim A.
    Merchan, Jaime R.
    Wilding, George
    Ginsberg, Michelle S.
    Bacik, Jennifer
    Kim, Sindy T.
    Baum, Charles M.
    Michaelson, M. Dror
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (21): : 2516 - 2524
  • [10] Individualized dosing schedule of sunitinib switched through plasma concentration monitoring in patients with metastatic renal cell carcinoma
    Zhu, Xudong
    Zhang, Xingming
    Zhang, Haoran
    Ni, Yuchao
    Dai, Jindong
    Sun, Guangxi
    Zhu, Sha
    Chen, Junru
    Zhao, Jinge
    Wang, Zhipeng
    Zeng, Hao
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
12345